The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Information for Authors. For additional details about all these topics, see Copyright, Permissions and Access. See Publication Fees for further details. Please share with the community how many days the entire process took by the editor's office. Philadelphia, PA 19106-4404 eISSN: 1557-3125 ISSN: 1541-7786, Cancer Epidemiology, Biomarkers & Prevention, Spotlight on Genomic Analysis of Rare and Understudied Cancers. How many rounds of external review did you go through ?
Journal of Clinical Oncology, Authors should be familiar with these instructions prior to submitting their work to the journal. Molecular Cancer Research Review Speed. Please share with the community how many days the entire process took by the editor's office. By the time you have accrued enough data to write a manuscript, you will likely want to publish as soon as possible. Cancer Cell, eISSN: 1557-3125 People also search for: For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions. Molecular Cancer Research's journal/conference profile on Publons, with 231 reviews by 115 reviewers - working with reviewers, publishers, institutions, and funding agencies to turn peer review into a measurable research output. Drug Resistance Updates, If your manuscript is sent to reviewers, please share with the community how many days the evaluated process took by editor's office (not include the evaluated process of reviewers). The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers Benjamin Verret , Tony Sourisseau , Bojana Stefanovska , Fernanda Mosele , Alicia Tran-Dien and Fabrice André
The average number of reviewers during the entire peer-reviewed process (include both accepted and rejected manuscript).
Cancer Research (Q1), Molecular Biology (Q1), Oncology (Q1). Nature Reviews Cancer, At the time, she molecular cancer research was eight months pregnant and had left the job of an assistant dietitian in A23 area restaurant. E-mail: [email protected], Molecular Cancer Research Editorial Office Molecular Cancer Research publishes two types of OnlineFirst articles.. OnlineFirst Author Manuscripts are PDF versions of manuscripts that have been peer reviewed and accepted for publication, but not yet copyedited or typeset, allowing readers the most rapid access to accepted papers.
The average number of days between the date of manuscript submission and date of receiving the editorial decision after the first review round (only the manuscript with peer-reviewed process). OnlineFirst articles are published online before they appear in a regular issue of the journal. American Association for Cancer Research 615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404 Phone: (215) 440-9300 | Fax: (215) 440-9354 | E-mail: [email protected] Rapid publication can accelerate the dissemination of findings, decrease the likelihood of being scooped, and allow a quicker return to the laboratory to work on the next study. By the time you have accrued enough data to write a manuscript, you will likely want to publish as soon as possible. Copyright © 2020 by the American Association for Cancer Research. The average number of days from manuscript submission to the initial editorial decision on the article. Phone: (215) 440-9300 | Fax: (215) 440-9411 | E-mail: [email protected].
615 Chestnut Street, 17th Floor more.
See Editorial Board for more information. How many reviewers are in the entire revision process ? American Association for Cancer Research The outcome is the development of a nearby or distant discontiguous secondary mass.
How many days did the entire process take ? Toll Free: (855) 744-4667 or (215) 440-9300 Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Scope. Molecular Cancer Research welcomes submissions of primary research, review and commentary article types as well as letters to the editor. Write a Review See All Reviews.
Copyright © 2020 by the American Association for Cancer Research.
The process involves a complex interplay between intrinsic tumor cell properties as well as interactions between cancer cells and multiple microenvironments. IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer Janielle P. Maynard , Onur Ertunc , Ibrahim Kulac , Javier A. Baena-Del Valle , Angelo M. De Marzo and Karen S. Sfanos Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes.
Please share your experiences with the community. All-trans retinoic acid, by inhibiting Pin1 and destabilizing BRCA1, extends benefit of PARP inhibitors to patients with homologous recombination–proficient tumors. ISSN: 1541-7786, Antibody–Drug Conjugates: A Comprehensive Review, A Bispecific Antibody Targeting the αv and α5β1 Integrins Induces Integrin Degradation in Prostate Cancer Cells and Is Superior to Monospecific Antibodies, Centrosome Amplification in Cancer Disrupts Autophagy and Sensitizes to Autophagy Inhibition, Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell–like Properties in Osteosarcoma, A TAZ–ANGPTL4–NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer, Inhibition of the ATR–CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2, Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer, Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting Colorectal Cancer Cells into Differentiated Normal-Like Cells, Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis, RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer, IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer, PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages, Genomics of Canine Hemangiosarcoma and Human Angiosarcoma, Modeling Loss of IDH1 R132H by CRISPR-Cas9, HILPDA Controls Lipid Metabolism Under Stress, BORIS Increases Invasion of Ovarian Cancer Precursor Cells, Cancer Epidemiology, Biomarkers & Prevention, Spotlight on Genomic Analysis of Rare and Understudied Cancers. The average number of days from manuscript acceptance to the first appearance of the article online. Metastasis is the primary cause of cancer morbidity and mortality. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting.
Research is often a slow process, requiring the careful design, optimization, and replication of experiments. Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication. Molecular Cancer Research Submitting authors must be familiar with the Editorial Policies of the AACR Journals covering important information on authorship, publishing ethics, availability of materials and data and data analysis and reporting. If your manuscript is rejected by the editor without the peer-reviewed process, please share with the community how many days you got the rejection email from the editor's office. Authors who wish to publish in the journal must formally transfer copyright to the AACR, but are granted considerable reuse rights. Submit your article to Molecular Cancer Research. If no financial support exists, authors may apply for a waiver of the fixed publication fee at the time of submission. The average number of days between the date of manuscript submission and date of receiving the editorial acceptance decision. Cell Host and Microbe, Subject to availability, single or back issues of Clinical Research may be purchased for $60 per copy in the U.S. or $65 per copy outside the U.S. For more information, contact: AACR Publications Sales & Marketing Department 【Molecular Cancer】CiteScore Trend Comments from Authors * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. (0 is also possible). Research is often a slow process, requiring the careful design, optimization, and replication of experiments. Please share with the community how many days the entire process took by the editor's office. Please note that Molecular Cancer Research does not consider appeals. Molecular Cancer Research is abstracted and/or indexed in BIOSIS Previews (R) Database, MEDLINE, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. After molecular cancer research the invention of the force field protective cover, it was more aggressive and difficult to stop. To defray publication costs and to support other AACR programs, publication in Molecular Cancer Research involves the payment of a fixed publication fee and an additional fee for any color figures. Editorial oversight of Molecular Cancer Research and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Boardwith support from journal staff. PARP inhibitors has been limited to treat homologous recombination–deficient tumors. 615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404 The final typeset version of every published article is rendered freely accessible 12 months after publication. Authors who prefer for their article to be immediately freely accessible online may make this selection by paying an additional fee through the AACR AuthorChoice option. For detailed metrics about Molecular Cancer Research and the other AACR journals see AACR Journals Metrics.
Please share with the community how many days the entire process took by the editor's office. The average number of external revision rounds during the entire peer-reviewed process (include both accepted and rejected manuscript). The average number of days from manuscript submission to the first appearance of the article online. American Association for Cancer Research | Publications Division Molecular Cancer Research (MCR) (Print ISSN: 1541-7786; Online ISSN 1557-3125) is published monthly, one volume/year, by the American Association for Cancer Research, Inc. (AACR).
For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.
Material published in Molecular Cancer Research is covered and protected by copyright. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Molecular Cancer Research Whether you are currently performing experiments or are in the midst of writing, the following Molecular Cancer Research - Review Speed data may help you to select an efficient and right journal for your manuscripts.
Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field.